Skip to main content

Lifestyle interventions

Prediabetes

10-24-2023 | Type 2 diabetes | News

Prediabetes remission with lifestyle intervention reduces type 2 diabetes risk

A post-hoc analysis of the German Prediabetes Lifestyle Intervention Study has found that people who achieve remission of prediabetes by losing weight through lifestyle intervention for 12 months may reduce their risk for developing type 2 diabetes.

07-12-2022 | Physical activity | News

10,000 steps per day optimal in diabetes or prediabetes

Even small increases in the number of steps taken in a day is associated with a reduced risk for mortality in people with prediabetes or diabetes, say researchers.

07-07-2022 | Risk factors | News

Smoking ‘important risk factor’ for albuminuria in people with prediabetes

Smoking is associated with an increased risk for albuminuria in both people with prediabetes and those with diabetes, but quitting may not immediately circumvent this risk, researchers report.

06-01-2022 | Cardiovascular outcomes | News

No long-term CV benefits seen 2 decades after DPP interventions

People with impaired glucose tolerance who received metformin or intensive lifestyle intervention during the DPP trial show no sign of a significantly reduced cardiovascular disease risk 21 years later, reveal the latest DPPOS results.

07-09-2021 | Obesity | News

Brain MRI offers clues to weight regain after surgery vs diet

Divergent changes in brain activity after bariatric surgery versus a very-low-calorie diet may help explain why people are more likely to regain weight after the latter intervention, a study suggests.

02-23-2021 | Diabetes prevention | News

Stabilizing IGT for a time has significant long-term vascular benefits

Delaying progression from impaired glucose tolerance to type 2 diabetes reduces the risk for micro- and macrovascular complications, shows 24 years of follow-up of the Da Qing trial.

Fallen stick figure in a race reaching for help

07-10-2020 | Prediabetes | Highlight | News

Key danger times identified for US Diabetes Prevention Program dropout

Focusing efforts on convincing people to return after the first session of the US National Diabetes Prevention Program lifestyle change program, and after the transition to less frequent sessions, may help to optimize program retention, say researchers.

Women with headscarfs sitting in Barcelona city

07-02-2020 | Prediabetes | Highlight | News

Neighborhood walkability may reduce ethnic disparities in diabetes risk

The increased risk for prediabetes among ethnic minorities compared with White people is less pronounced in neighborhoods with high walkability, shows a Canadian study.

Tablet device showing the chemical structure of Metformin

06-16-2020 | ADA 2020 | Conference coverage | News

DPPOS: No change to cancer risk with long-term metformin use

Among the latest findings from the DPP Outcomes Study is that long-term use of metformin does not affect the risk for cancer.

12-05-2019 | Diet | News

Time-restricted eating acceptable and beneficial for people with metabolic syndrome

Restricting eating to within a 10-hour daily window results in weight loss and metabolic benefits for people with metabolic syndrome, report researchers in Cell Metabolism.

Electronic health records

11-11-2019 | Obesity | Highlight | News

Online coaching helps with weight loss maintenance

People who are trying to maintain weight loss with the help of electronic health records-based tracking tools do significantly better if they are given access to an online coach, shows a randomized trial.

Nutrition therapy for diabetes: A marathon, not a sprint

09-10-2019 | Diet | Editorial | Article

Nutrition therapy for diabetes: A marathon, not a sprint

What's new in the 2019 update to the ADA guidelines on nutrition therapy for adults with diabetes or prediabetes? Diabetes Educator Amy Hess Fischl explains.

08-21-2019 | Diet | News

Lack of omega-3 effect on type 2 diabetes confirmed

A systematic review and meta-analysis published in The BMJ confirms that intake of omega-3 fats does not influence the risk for or progression of type 2 diabetes.

07-01-2019 | Ethnic groups | News

Lifestyle interventions reduce diabetes risk in South Asians

Meta-analysis data show that lifestyle modification interventions can reduce the risk for developing type 2 diabetes by more than a third in high-risk adults of South Asian origin.

06-03-2019 | Lifestyle interventions | News

Extended behavioral intervention suggested for optimal glycemic control

Obese adults with prediabetes may need a longer-than-recommended course of behavioral weight loss treatment to optimize improvements in glycemic control, US researchers report.

04-26-2019 | Diabetes prevention | News

Da Qing study: Lifestyle intervention benefits persist for decades

Lifestyle interventions to delay the onset of type 2 diabetes result in marked long-term reductions in cardiovascular disease and mortality, shows the 30-year follow-up of the Da Qing Diabetes Prevention Outcome Study.

04-23-2019 | Metformin | News

Metformin may help people at high diabetes risk to maintain weight loss

Fifteen years of follow-up of the DPP trial shows that although people initially lost more weight with the intensive lifestyle intervention, those assigned to metformin did better at keeping the weight off in the long term.

Healthy diet

10-09-2018 | Diabetes prevention | EASD 2018 | News

Mixed results from the diabetes prevention PREVIEW project

The PREVIEW project investigators have reported broadly positive results, but tempered by issues such as a high dropout rate.

Amrit Lamba

10-08-2018 | Diabetes prevention | EASD 2018 | Article

Expert commentary: The PREVIEW project

Amrit Lamba considers the rather mixed results of the PREVIEW project, and what they mean for primary care (3:40).

08-08-2018 | Physical activity | News

Physical activity of high importance in prediabetes

Physical inactivity is a “significant but underappreciated contributor” to the risk of developing diabetes in people who are already at high risk and should be routinely measured in clinical trials, say the NAVIGATOR investigators.